Gardasil News and Research

RSS
Gardasil is a vaccine that prevents the types of genital human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts. The vaccine, Gardasil, is given in three shots over six-months. The vaccine is routinely recommended for 11 and 12 year old girls. It is also recommended for girls and women age 13 through 26 who have not yet been vaccinated or completed the vaccine series.
HPV may be responsible for the alarming numbers of oral cancers: Study

HPV may be responsible for the alarming numbers of oral cancers: Study

Viewpoints: Controlling entitlement spending; irrationality of bashing health overhaul; need for changes to state workers' benefits; Va. abortion rules

Viewpoints: Controlling entitlement spending; irrationality of bashing health overhaul; need for changes to state workers' benefits; Va. abortion rules

Bioethicists up the ante in Bachmann's HPV brouhaha

Bioethicists up the ante in Bachmann's HPV brouhaha

Merck issues statement on GARDASIL human papillomavirus vaccine

Merck issues statement on GARDASIL human papillomavirus vaccine

HPV vaccination updates

HPV vaccination updates

Longer looks: Doctors advocating less care; addiction as a 'disease'

Longer looks: Doctors advocating less care; addiction as a 'disease'

The Perry record on reform, Medicaid and HPV vaccinations

The Perry record on reform, Medicaid and HPV vaccinations

First Edition: August 18, 2011

First Edition: August 18, 2011

Skin cancer vaccine on the way: Cancer expert Prof Ian Frazer

Skin cancer vaccine on the way: Cancer expert Prof Ian Frazer

Merck reports worldwide sales of $12.2 billion for second quarter 2011

Merck reports worldwide sales of $12.2 billion for second quarter 2011

DNA vaccine developer Coridon in U.S. collaboration

DNA vaccine developer Coridon in U.S. collaboration

bioMD changes name to Allied Healthcare Group

bioMD changes name to Allied Healthcare Group

bioMD (BOD) announces new MD, new Chairman and Board

bioMD (BOD) announces new MD, new Chairman and Board

HPV vaccination does not affect rate of disease flares in patients with SLE, study finds

HPV vaccination does not affect rate of disease flares in patients with SLE, study finds

New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

New GARDASIL data against Human Papillomavirus presented at EUROGIN conference

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Inovio reports VGX-3100 Phase I study data in cervical dysplasia and cancer

Rwanda launches Africa's first nationwide cervical cancer vaccination, detection program

Rwanda launches Africa's first nationwide cervical cancer vaccination, detection program

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

TCI forecasts cancer vaccine market to approach $3 billion in 2015

TCI forecasts cancer vaccine market to approach $3 billion in 2015